Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Treatment
Share your love
Arcan’s Insight® 100 Ultrasound Approved in China
ArcScan, a global medical technology company dedicated to revolutionizing ophthalmic care, marked a significant milestone with the announcement of the National Medical Products Administration (NMPA) approval of its flagship product, the ArcScan Insight® 100, for use in China. Addressing the…
EyeCRO Unveils Clinical Data for MiDROPS Technology
EyeCRO recently announced the results from the inaugural clinical application of its MiDROPS (Microemulsion Drug Ocular Penetration System) technology, presented by Telios Pharma at the Association for Research in Vision and Ophthalmology (ARVO) meeting held in Seattle, WA. The presentation,…
Smart Contact Lens Monitors Pressure in Any Temperature
Researchers have developed a prototype “smart” contact lens that accurately measures eye pressure regardless of temperature, according to a study in ACS Applied Materials & Interfaces. Around 3 million people in the U.S. suffer from glaucoma, according to the Centers…
What is Retinopathy of Prematurity and What Causes it
Retinopathy of Prematurity is one of the critical challenges in neonatal care, especially for premature babies born before 31 weeks of gestation and known as grams weighing less than 1,500. This disease, expressing itself as impaired or even complete abnormalities in…
Oculis Finalizes Phase 2 Trial Enrollment for OCS-05 in AON
Oculis has completed enrollment in its multicenter, randomized, double-blind, placebo-controlled phase 2 ACUITY trial evaluating the safety and tolerability of OCS-05 in patients with Acute Optic Neuritis (AON). Topline results are expected in Q4 2024. The phase 2 ACUITY study…
Smart Contact Lenses for Blood Glucose Monitoring
Researchers at Yonsei University, along with their counterparts from other leading institutions, announced a significant breakthrough in diabetes management with the development of smart contact lenses. These lenses are capable of analyzing components in tears to monitor blood glucose levels…
UV Radiation at Outdoor Events Linked to Photokeratitis
In a recent publication in JAMA Ophthalmology, researchers have highlighted the potential dangers of ultraviolet (UV) radiation during outdoor recreational activities, particularly pointing to its association with photokeratitis. The study, led by Julia Y.Y. Chan, M.B.B.S., from the Chinese University…
Staar Surgical and IQ Laser Vision Expand EVO ICL Use in the US
Staar Surgical announced a strategic partnership with IQ Laser Vision, a prominent vision correction organization with locations throughout California and Texas. This collaboration aims to significantly increase the use of EVO ICL lenses for surgical vision correction, specifically targeting patients…
AsclepiX Completes Enrollment in DISCOVER Trial for Wet AMD
AsclepiX Therapeutics has successfully completed the enrollment for the DISCOVER trial (NCT05859776), which evaluates the safety and tolerability of three different doses of AXT107 (gersizangitide) in patients with wet Age-related Macular Degeneration (AMD). Trial Design and Objectives The trial includes…
EyePoint’s Duravyu Misses Phase 2 NPDR Trial Goal
EyePoint Pharmaceuticals announced the topline results from its phase 2 PAVIA clinical trial, which evaluated the efficacy of Duravyu (vorolanib intravitreal insert), formerly known as EYP-1901, in treating non-proliferative diabetic retinopathy (NPDR). The trial revealed that Duravyu did not achieve…